Hot and bothered
Today, Explained
00:00
Intro
This chapter highlights the FDA approval of Fezolinotan, marking a significant advancement in the treatment of menopause-related hot flashes. It also addresses the cultural stigma and lack of resources surrounding menopause, emphasizing the need for greater awareness and discussion about women's health during this stage of life.
Transcript
Play full episode
